RNA FY 2021 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

RNAAvidity Biosciences, Inc.

$2B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$9M+37.4% YoY

Gross Profit

-$92M-984.9% margin

Operating Income

-$118M-1265.8% margin

Net Income

-$118M-1265.4% margin

EPS (Diluted)

$-2.85

Cash Flow

Operating Cash Flow

-$95M

Free Cash Flow

-$99M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$428M

Total Liabilities

$46M

Stockholders' Equity

$381M

Cash & Equivalents

$320M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$7M	+37.4%
Gross Profit	-$92M	-$31M	-198.1%
Operating Income	-$118M	-$44M	-166.6%
Net Income	-$118M	-$44M	-166.1%